A potentially life-saving new treatment for children with a rare form of leukaemia is being made available on the NHS – but a drug for adults with blood cancer has been rejected.
The Scottish Medicines Consortium (SMC) has approved the use of Kymriah – which is also known as tisagenlecleucel – for children and young people suffering from acute lymphoblastic lymphoma.
Share Token
www.heraldscotland.com/news/17425174.nhs-approve-drug-to-fight-child-cancer/